Every time we speak, we're improvising. "Humans possess a remarkable ability to talk about almost anything, sometimes putting ...

Vast's first platform, Haven-1, is deliberately modest in scale but ambitious in both schedule and purpose. The station is designed as a roughly 15-ton autonomous outpost ...

Recently, JinkoSolar, a globally innovative photovoltaic enterprise, announced a strategic partnership with a renowned UK clean energy distributor, successfully securing a 56.89MW order for its ...

Structure Therapeutics CEO Ray Stevens talked about the biotech’s path forward and his expectations for the future of the ...

LONGi Green, Tongwei, JA Solar, TCL Zhonghuan and Aiko Solar are projecting a combined 2025 deficit of RMB28.9-32.8 billion ...

Sentiment among Europe’s solar buyers dropped to the lowest levels on record at the end of 2025, according to sun.store's ...

Until today, Haven-1 had a public launch date of mid-2026. However, as Haot explained in our interview, that launch date is ...

The proposed Coordinate-Aware Feature Excitation (CAFE) module and Position-Aware Upsampling (Pos-Up) module both adhere to ...

Goertek, a key player in the extended reality (XR) ecosystem, marked its presence at this year’s CES in Las Vegas, which ...

Structure Therapeutics (GPCR) just moved its obesity pipeline up a gear by kicking off a first in human Phase 1 trial for ACCG-2671, its oral amylin receptor agonist targeting metabolic disease. See ...

SAN FRANCISCO, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for ...

The IMCAS test team for the reconfigurable flexible on-orbit manufacturing platform. Credit: IMCAS HELSINKI — A Chinese institute recently completed ground tests on what it describes as a ...